Skip to main content
Clinical Trials/NCT03930160
NCT03930160CompletedNot Applicable

Logistic Organ Dysfunction System Role in Predicting 30-day Mortality Outcome in Intensive Care Unit of dr. Cipto Mangunkusumo General Hospital Patients

Indonesia University1 site in 1 country439 target enrollmentStarted: May 17, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
439
Locations
1
Primary Endpoint
Correlation between LODS score variables with patient outcome

Study Overview

Brief Summary

LODS score for deceased ICU patients within 30 days is higher than survived ICU patients

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • adult patient (age 18 years and above) admitted to ICU

Exclusion Criteria

  • patients admitted to ICU due to burn injury, coronary artery disease, post cardiac surgery
  • patients with incomplete required information for LODS score
  • patients deceased or discharged less than 24 hours of admission

Outcomes

Primary Outcomes

Correlation between LODS score variables with patient outcome

Time Frame: 30 days from admission

Correlation between patient outcomes with each LODS score variables: GCS; heart rate; systolic BP; blood urea; serum creatinine; urine output; leucocyte count; platelet count; PaO2/FiO2; serum bilirubin; prothrombin time.

LODS score discrimination ability

Time Frame: 30 days from admission

LODS score ability to discriminate patient outcomes based on variables of logistic organ dysfunction system scores: GCS; heart rate; systolic BP; blood urea; serum creatinine; urine output; leucocyte count; platelet count; PaO2/FiO2; serum bilirubin; prothrombin time.

LODS score calibration

Time Frame: 30 days from admission

LODS score ability to predict patient outcomes based on variables of logistic organ dysfunction system scores: GCS; heart rate; systolic BP; blood urea; serum creatinine; urine output; leucocyte count; platelet count; PaO2/FiO2; serum bilirubin; prothrombin time.

Secondary Outcomes

  • LODS neurologic variable score: Glasgow Coma Scale (GCS)(Day 1)
  • LODS cardiovascular variable score: Heart rate (HR) and/or systolic blood pressure (SBP)(Day 1)
  • LODS pulmonary variable score: Partial oxygen pressure (PaO2)/Fraction of inspired oxygen (FiO2) on Mechanical Ventilation (MV) or Continuous Positive Airway Pressure (CPAP)(Day 1)
  • Patient outcome(30 days from admission)
  • LODS hematologic variable score: white blood cell (WBC) count and/or platelet count(Day 1)
  • LODS renal variable score: serum urea nitrogen (BUN) and/or creatinine and/or urine output (UO)(Day 1)
  • LODS hepatic function variable score: Serum Bilirubin and/or Prothrombin time (PT)(Day 1)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dita Aditianingsih

MD, PhD, Anesthesiologist Consultant

Indonesia University

Study Sites (1)

Loading locations...

Similar Trials